Recovery Protocol
8 weeks
BPC-157 + TB-500 synergistic repair cascade for accelerated tissue healing and systemic recovery. BPC-157 acts locally at injury sites, driving angiogenesis and collagen synthesis through VEGFR2 and FAK-paxillin pathway activation. TB-500 complements this with systemic distribution, mobilising stem cells and promoting cell migration through G-actin sequestration. Together they cover inflammation suppression, proliferation, and tissue remodelling in sequence.
Weekly Schedule
Weeks 1–2
BPC-157: 200–400 mcg once daily subcutaneous. TB-500: 500 mcg once daily subcutaneous.
Weeks 3–4
BPC-157: 400 mcg once daily. TB-500: 600 mcg once daily.
Weeks 5–8
BPC-157: 600 mcg once daily. TB-500: 750–1000 mcg once daily.
Important Notes
- ✓Reconstitute each 10mg vial with 3mL bacteriostatic water (BPC-157: ~3.33 mg/mL, TB-500: ~3.33 mg/mL).
- ✓Store reconstituted vials at 2–8°C and use within 28–30 days.
- ✓BPC-157 is most effective when injected subcutaneously near the target area.
- ✓TB-500 is systemically distributed regardless of injection site.
- ✓For research and laboratory purposes only.